Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD)

References

• Hesson J, Fowler K. Prevalence and correlates of self-reported ADD/ADHD in a large national sample of canadian adults. J Atten Disord. 2018 Jan;22(2):191–200. PubMed PMID: 25749874.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry. 2006 Sep;163(9):1561–1568. PubMed PMID: 16946181; PubMed Central PMCID: PMCPMC1924724.
   PubMed Web of Science ®Google Scholar
• Kooij JJ, Huss M, Asherson P, et al. Distinguishing comorbidity and successful management of adult ADHD. J Atten Disord. 2012 Jul;16(5 Suppl):3S–19S. PubMed PMID: 22498754.
   PubMed Web of Science ®Google Scholar
• Barkley RA. Distinguishing sluggish cognitive tempo from attention-deficit/hyperactivity disorder in adults. J Abnorm Psychol. 2012 Nov;121(4):978–990 PubMed PMID: 21604823.
   PubMed Web of Science ®Google Scholar
• Mao AR, Findling RL. Comorbidities in adult attention-deficit/hyperactivity disorder: a practical guide to diagnosis in primary care. Postgrad Med. 2014 Sep;126(5):42–51. PubMed PMID: 25295649.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006 Feb;36(2):159–165. PubMed PMID: 16420712.
   PubMed Web of Science ®Google Scholar
• Klein RG, Mannuzza S, Olazagasti MA, et al. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry. 2012 Dec;69(12):1295–1303. PubMed PMID: 23070149; PubMed Central PMCID: PMCPMC3597443.
   PubMed Web of Science ®Google Scholar
• Brookes K, Xu X, Chen W, et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry. 2006 Oct;11(10):934–953. PubMed PMID: 16894395.
   PubMed Web of Science ®Google Scholar
• de Graaf R, Kessler RC, Fayyad J, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health survey initiative. Occup Environ Med. 2008 Dec;65(12):835–842. PubMed PMID: 18505771; PubMed Central PMCID: PMCPMC2665789.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry. 2006 Apr;163(4):716–723. PubMed PMID: 16585449; PubMed Central PMCID: PMCPMC2859678.
   PubMed Web of Science ®Google Scholar
• Rucklidge JJ. Gender differences in attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2010 Jun;33(2):357–373. PubMed PMID: 20385342.
   PubMed Web of Science ®Google Scholar
• Wehmeier PM, Schacht A, Barkley RA. Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. J Adolesc Health. 2010 Mar;46(3):209–217. PubMed PMID: 20159496.
   PubMed Web of Science ®Google Scholar
• Shaw P, Stringaris A, Nigg J, et al. Emotion dysregulation in attention deficit hyperactivity disorder. Am J Psychiatry. 2014 Mar;171(3):276–293. PubMed PMID: 24480998; PubMed Central PMCID: PMCPMC4282137.
   PubMed Web of Science ®Google Scholar
• Koob GF. Negative reinforcement in drug addiction: the darkness within. Curr Opin Neurobiol. 2013 Aug;23(4):559–563. PubMed PMID: 23628232.
   PubMed Web of Science ®Google Scholar
• Seeman P. Parkinson’s disease treatment may cause impulse-control disorder via dopamine D3 receptors. Synapse. 2015 Apr;69(4):183–189. PubMed PMID: 25645960.
   PubMed Web of Science ®Google Scholar
• Phillips ML, Ladouceur CD, Drevets WC. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry. 2008 Sep;13(9):829, 833–57. PubMed PMID: 18574483; PubMed Central PMCID: PMCPMC2745893.
   Web of Science ®Google Scholar
• Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex. 2000 Mar;10(3):318–325. PubMed PMID: 10731226.
   PubMed Web of Science ®Google Scholar
• Bush G, Valera EM, Seidman LJ. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol Psychiatry. 2005 Jun 1;57(11):1273–1284. PubMed PMID: 15949999.
   PubMed Web of Science ®Google Scholar
• Cortese S, Kelly C, Chabernaud C, et al. Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. Am J Psychiatry. 2012 Oct;169(10):1038–1055. PubMed PMID: 22983386; PubMed Central PMCID: PMCPMC3879048.
   PubMed Web of Science ®Google Scholar
• Hart H, Radua J, Nakao T, et al. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry. 2013 Feb;70(2):185–198. PubMed PMID: 23247506.
   PubMed Web of Science ®Google Scholar
• Damasio AR. Descartes’ error and the future of human life. Sci Am. 1994 Oct;271(4):144. PubMed PMID: 7939563.
   PubMed Web of Science ®Google Scholar
• Fuster JM. The prefrontal cortex–an update: time is of the essence. Neuron. 2001 May;30(2):319–333. PubMed PMID: 11394996.
   PubMed Web of Science ®Google Scholar
• Achenbach TMRL ASEBA School Age Forms and Profiles. 2001.
   Google Scholar
• Torgersen T, Gjervan B, Rasmussen K. ADHD in adults: a study of clinical characteristics, impairment and comorbidity. PubMed PMID: 16500798 Nord J Psychiatry. 2006;601:38–43.
   PubMed Web of Science ®Google Scholar
• Perugi G, Ceraudo G, Vannucchi G, et al. Attention deficit/hyperactivity disorder symptoms in Italian bipolar adult patients: a preliminary report. J Affect Disord. 2013 Jul;149(1–3):430–434. PubMed PMID: 23267727.
   PubMed Web of Science ®Google Scholar
• Masi G, Perugi G, Toni C, et al. Attention-deficit hyperactivity disorder – bipolar comorbidity in children and adolescents. Bipolar Disord. 2006 Aug;8(4):373–381. PubMed PMID: 16879138.
   PubMed Web of Science ®Google Scholar
• Meinzer MC, Pettit JW, Leventhal AM, et al. Explaining the covariance between attention-deficit hyperactivity disorder symptoms and depressive symptoms: the role of hedonic responsivity. J Clin Psychol. 2012 Oct;68(10):1111–1121. PubMed PMID: 22777931; PubMed Central PMCID: PMCPMC4196856.
   PubMed Web of Science ®Google Scholar
• Duran S, Fistikci N, Keyvan A, et al. [ADHD in adult psychiatric outpatients: prevalence and comorbidity]. Turk Psikiyatri Derg. 2014 Summer;25(2):84–93. PubMed PMID: 24936755.
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993 Dec;150(12):1792–1798. PubMed PMID: 8238632.
   PubMed Web of Science ®Google Scholar
• Minde K, Eakin L, Hechtman L, et al. The psychosocial functioning of children and spouses of adults with ADHD. J Child Psychol Psychiatry. 2003 May;44(4):637–646. PubMed PMID: 12751853.
   PubMed Web of Science ®Google Scholar
• Harpold T, Biederman J, Gignac M, et al. Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHD. J Nerv Ment Dis. 2007 Jul;195(7):601–605. PubMed PMID: 17632251.
   PubMed Web of Science ®Google Scholar
• Ambrosini PJ, Bennett DS, Elia J. Attention deficit hyperactivity disorder characteristics: II. Clinical correlates of irritable mood. J Affect Disord. 2013 Feb 15;145(1):70–76 PubMed PMID: 22868057; PubMed Central PMCID: PMCPMC3496809.
   PubMed Web of Science ®Google Scholar
• Angold A, Costello EJ, Erkanli A. Comorbidity. J Child Psychol Psychiatry. 1999 Jan;40(1):57–87. PubMed PMID: 10102726.
   PubMed Web of Science ®Google Scholar
• Secnik K, Swensen A, Lage MJ. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics. 2005;23(1): 93–102. PubMed PMID: 15693731.
   PubMed Web of Science ®Google Scholar
• Solberg BS, Halmoy A, Engeland A, et al. Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder. Acta Psychiatr Scand. 2018 Mar;137(3):176–186. PubMed PMID: 29266167; PubMed Central PMCID: PMCPMC5838558.
   PubMed Web of Science ®Google Scholar
• Bussing R, Koro-Ljungberg ME, Gary F, et al. Exploring help-seeking for ADHD symptoms: a mixed-methods approach. Harv Rev Psychiatry. 2005 Mar-Apr;13(2):85–101. PubMed PMID: 16020023.
   PubMed Web of Science ®Google Scholar
• Robison LM, Sclar DA, Skaer TL, et al. Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99. Int Clin Psychopharmacol. 2004 Jan;19(1):17–22. PubMed PMID: 15101565.
   PubMed Web of Science ®Google Scholar
• Wingo AP, Ghaemi SN. A systematic review of rates and diagnostic validity of comorbid adult attention-deficit/hyperactivity disorder and bipolar disorder. J Clin Psychiatry. 2007 Nov;68(11):1776–1784. PubMed PMID: 18052572.
   PubMed Web of Science ®Google Scholar
• Tamam L, Karakus G, Ozpoyraz N. Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates. Eur Arch Psychiatry Clin Neurosci. 2008 Oct;258(7):385–393 PubMed PMID: 18437277.
   PubMed Web of Science ®Google Scholar
• Tamam L, Tuglu C, Karatas G, et al. Adult attention-deficit hyperactivity disorder in patients with bipolar I disorder in remission: preliminary study. Psychiatry Clin Neurosci. 2006 Aug;60(4):480–485. PubMed PMID: 16884451.
   PubMed Web of Science ®Google Scholar
• Ryden E, Thase ME, Straht D, et al. A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD. Acta Psychiatr Scand. 2009 Sep;120(3):239–246. PubMed PMID: 19426162.
   PubMed Web of Science ®Google Scholar
• Klassen LJ, Katzman MA, Chokka P. Adult ADHD and its comorbidities, with a focus on bipolar disorder. J Affect Disord. 2010 Jul;124(1–2):1–8. PubMed PMID: 19683348.
   PubMed Web of Science ®Google Scholar
• Karaahmet E, Konuk N, Dalkilic A, et al. The comorbidity of adult attention-deficit/hyperactivity disorder in bipolar disorder patients. Compr Psychiatry. 2013 Jul;54(5):549–555. PubMed PMID: 23306036.
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, Miyahara S, Spencer T, et al. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005 Jun 1;57(11):1467–1473. PubMed PMID: 15950022.
   PubMed Web of Science ®Google Scholar
• Bond DJ, Hadjipavlou G, Lam RW, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Ann Clin Psychiatry. 2012 Feb;24(1):23–37. PubMed PMID: 22303520.
   PubMed Web of Science ®Google Scholar
• Scheffer RE, Kowatch RA, Carmody T, et al. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry. 2005 Jan;162(1):58–64. PubMed PMID: 15625202.
   PubMed Web of Science ®Google Scholar
• Findling RL, Short EJ, McNamara NK, et al. Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007 Nov;46(11):1445–1453. PubMed PMID: 18049294.
   PubMed Web of Science ®Google Scholar
• Tramontina S, Zeni CP, Ketzer CR, et al. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial. J Clin Psychiatry. 2009 Apr 21;70(5):756–764. PubMed PMID: 19389329.
   PubMed Web of Science ®Google Scholar
• Chang K, Nayar D, Howe M, et al. Atomoxetine as an adjunct therapy in the treatment of co-morbid attention-deficit/hyperactivity disorder in children and adolescents with bipolar I or II disorder. J Child Adolesc Psychopharmacol. 2009 Oct;19(5):547–551. PubMed PMID: 19877979.
   PubMed Web of Science ®Google Scholar
• McGough JJ, Smalley SL, McCracken JT, et al. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry. 2005 Sep;162(9):1621–1627. PubMed PMID: 16135620.
   PubMed Web of Science ®Google Scholar
• Cadman T, Findon J, Eklund H, et al. Six-year follow-up study of combined type ADHD from childhood to young adulthood: predictors of functional impairment and comorbid symptoms. Eur Psychiatry. 2016 May;35:47–54. PubMed PMID: 27077377.
   PubMed Web of Science ®Google Scholar
• Rosler M, Retz W, Fischer R, et al. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry. 2010 Aug;11(5):709–718. PubMed PMID: 20353312.
   PubMed Web of Science ®Google Scholar
• Reimherr FW, Marchant BK, Gift TE, et al. Types of adult attention-deficit hyperactivity disorder (ADHD): baseline characteristics, initial response, and long-term response to treatment with methylphenidate. Atten Defic Hyperact Disord. 2015 Jun;7(2):115–128. PubMed PMID: 25987323.
   PubMedGoogle Scholar
• Philipsen A, Jans T, Graf E, et al. Effects of group psychotherapy, individual counseling, methylphenidate, and placebo in the treatment of adult attention-deficit/hyperactivity disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Dec;72(12):1199–1210. PubMed PMID: 26536057.
   PubMed Web of Science ®Google Scholar
• Marchant BK, Reimherr FW, Robison RJ, et al. Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms. J Atten Disord. 2011 May;15(4):295–304. PubMed PMID: 20410322.
   PubMed Web of Science ®Google Scholar
• Adler LA, Dirks B, Deas PF, et al. Lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2013 Jul;74(7):694–702. PubMed PMID: 23945447.
   PubMed Web of Science ®Google Scholar
• Dorrego MF, Canevaro L, Kuzis G, et al. A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings. J Neuropsychiatry Clin Neurosci. 2002 Summer;14(3):289–295. PubMed PMID: 12154153.
   PubMed Web of Science ®Google Scholar
• Reimherr FW, Marchant BK, Strong RE, et al. Emotional dysregulation in adult ADHD and response to atomoxetine. Biol Psychiatry. 2005 Jul 15;58(2):125–131. PubMed PMID: 16038683.
   PubMed Web of Science ®Google Scholar
• Adler LA, Clemow DB, Williams DW, et al. Atomoxetine effects on executive function as measured by the BRIEF-A in young adults with ADHD: a randomized, double-blind, placebo-controlled study. PLoS One. 2014;9(8):e104175. PubMed PMID: 25148243; PubMed Central PMCID: PMCPMC4141744.
   PubMed Web of Science ®Google Scholar
• Schulz KP, Clerkin SM, Fan J, et al. Guanfacine modulates the influence of emotional cues on prefrontal cortex activation for cognitive control. Psychopharmacology (Berl). 2013 Mar;226(2):261–271. PubMed PMID: 23086020; PubMed Central PMCID: PMCPMC3567242.
   PubMed Web of Science ®Google Scholar
• Fankhauser MP, Karumanchi VC, German ML, et al. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry. 1992 Mar;53(3):77–82. PubMed PMID: 1548248.
   PubMed Web of Science ®Google Scholar
• Leckman JF, Hardin MT, Riddle MA, et al. Clonidine treatment of Gilles de la Tourette’s syndrome. Arch Gen Psychiatry. 1991 Apr;48(4):324–328. PubMed PMID: 2009034.
   PubMed Web of Science ®Google Scholar
• Rasetti R, Mattay VS, Stankevich B, et al. Modulatory effects of modafinil on neural circuits regulating emotion and cognition. Neuropsychopharmacology. 2010 Sep;35(10):2101–2109. PubMed PMID: 20555311; PubMed Central PMCID: PMCPMC3013347.
   PubMed Web of Science ®Google Scholar
• Aman MG, Singh NN. Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior. Appl Res Ment Retard. 1982;3(4):345–358. PubMed PMID: 7168571.
   PubMedGoogle Scholar
• Aman MG, Kern RA, McGhee DE, et al. Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects. J Am Acad Child Adolesc Psychiatry. 1993 Jul;32(4):851–859. PubMed PMID: 8340309.
   PubMed Web of Science ®Google Scholar
• Moukhtarian TR, Cooper RE, Vassos E, et al. Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis. Eur Psychiatry. 2017 Jul;44:198–207. PubMed PMID: 28646732.
   PubMed Web of Science ®Google Scholar
• Lenzi F, Cortese S, Harris J, et al. Pharmacotherapy of emotional dysregulation in adults with ADHD: asystematic review and meta-analysis. Neurosci Biobehav Rev. 2018 Jan;84:359–367. PubMed PMID: 28837827.
   PubMed Web of Science ®Google Scholar
• Castells X, Ramos-Quiroga JA, Rigau D, et al. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs. 2011 Feb;25(2):157–169. PubMed PMID: 21254791.
   PubMed Web of Science ®Google Scholar
• Cunill R, Castells X, Tobias A, et al. Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression. Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):961–969. PubMed PMID: 23813665.
   PubMed Web of Science ®Google Scholar
• Reimherr FW, Williams ED, Strong RE, et al. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry. 2007 Jan;68(1):93–101. PubMed PMID: 17284136.
   PubMed Web of Science ®Google Scholar
• Prada P, Nicastro R, Zimmermann J, et al. Addition of methylphenidate to intensive dialectical behaviour therapy for patients suffering from comorbid borderline personality disorder and ADHD: a naturalistic study. Atten Defic Hyperact Disord. 2015 Sep;7(3):199–209. PubMed PMID: 25634471.
   PubMedGoogle Scholar
• Masi G, Perugi G, Millepiedi S, et al. Pharmacological response in juvenile bipolar disorder subtypes: anaturalistic retrospective examination. Psychiatry Res. 2010 May 15;177(1–2):192–198. PubMed PMID: 20381170.
   PubMed Web of Science ®Google Scholar
• Williams LM, Hermens DF, Palmer D, et al. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects. Biol Psychiatry. 2008 May 15;63(10):917–926. PubMed PMID: 18272140.
   PubMed Web of Science ®Google Scholar
• Conzelmann A, Woidich E, Mucha RF, et al. Methylphenidate normalizes emotional processing in adult patients with attention-deficit/hyperactivity disorder: preliminary findings. Brain Res. 2011 Mar 24;1381:159–166. PubMed PMID: 21215727.
   PubMed Web of Science ®Google Scholar
• Posner J, Maia TV, Fair D, et al. The attenuation of dysfunctional emotional processing with stimulant medication: an fMRI study of adolescents with ADHD. Psychiatry Res. 2011 Sep 30;193(3):151–160. PubMed PMID: 21778039; PubMed Central PMCID: PMCPMC3164556.
   PubMed Web of Science ®Google Scholar
• Asherson P, Stes S, Nilsson Markhed M, et al. The effects of atomoxetine on emotional control in adults with ADHD: an integrated analysis of multicenter studies. Eur Psychiatry. 2015 Jun;30(4):511–520. PubMed PMID: 25649490.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Biederman J, Faraone S, et al. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. Am J Psychiatry. 2001 Apr;158(4):611–617. PubMed PMID: 11282697.
   PubMed Web of Science ®Google Scholar
• Cools R, Roberts AC, Robbins TW. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci. 2008 Jan;12(1):31–40. PubMed PMID: 18069045.
   PubMed Web of Science ®Google Scholar
• Manos MJ, Brams M, Childress AC, et al. Changes in emotions related to medication used to treat ADHD. Part I: literature review. J Atten Disord. 2011 Feb;15(2):101–112. PubMed PMID: 20876887.
   PubMed Web of Science ®Google Scholar
• Jou R, Handen B, Hardan A. Psychostimulant treatment of adults with mental retardation and attention-deficit hyperactivity disorder. Australas Psychiatry. 2004 Dec;12(4):376–379. PubMed PMID: 15715811.
   PubMedGoogle Scholar
• Adler LA, Liebowitz M, Kronenberger W, et al. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety. 2009;26(3):212–221. PubMed PMID: 19194995.
   PubMed Web of Science ®Google Scholar
• Viktorin A, Ryden E, Thase ME, et al. The risk of treatment-emergent mania with methylphenidate in bipolar disorder. Am J Psychiatry. 2017 Apr 1;174(4):341–348. PubMed PMID: 27690517.
   PubMed Web of Science ®Google Scholar
• Lydon E, El-Mallakh RS. Naturalistic long-term use of methylphenidate in bipolar disorder. J Clin Psychopharmacol. 2006 Oct;26(5):516–518. PubMed PMID: 16974196.
   PubMed Web of Science ®Google Scholar
• Edvinsson D, Ekselius L. Long-term tolerability and safety of pharmacological treatment of adult attention-deficit/hyperactivity disorder: a 6-year prospective naturalistic study. J Clin Psychopharmacol. 2018 Aug;38(4):370–375. PubMed PMID: 29927781; PubMed Central PMCID: PMCPMC6039396.
   PubMed Web of Science ®Google Scholar
• El-Mallakh RS. An open study of methylphenidate in bipolar depression. Bipolar Disord. 2000 Mar;2(1):56–59. PubMed PMID: 11254021.
   PubMed Web of Science ®Google Scholar
• Carlson PJ, Merlock MC, Suppes T. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation. Bipolar Disord. 2004 Oct;6(5):416–420. PubMed PMID: 15383134.
   Google Scholar
• Parker G, Brotchie H. Do the old psychostimulant drugs have a role in managing treatment-resistant depression? Acta Psychiatr Scand. 2010 Apr;121(4):308–314. PubMed PMID: 19594481.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Alsuwaidan M, Soczynska JK, et al. The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder. Hum Psychopharmacol. 2013 Sep;28(5):421–427. PubMed PMID: 24014142.
   PubMed Web of Science ®Google Scholar
• Wang LJ, Shyu YC, Yuan SS, et al. Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: anationwide population-based study in Taiwan. J Psychiatr Res. 2016 Jan;72:6–14. PubMed PMID: 26519764.
   PubMed Web of Science ®Google Scholar
• Gabriel A. The mixed amphetamine salt extended release (Adderall XR, Max-XR) as an adjunctive to SSRIS or SNRIS in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety: an open-label study. Atten Defic Hyperact Disord. 2010 Jun;2(2):87–92. PubMed PMID: 21432593.
   PubMedGoogle Scholar
• Gabriel A, Violato C. Adjunctive atomoxetine to SSRIs or SNRIs in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety (GA): an open-label study. Atten Defic Hyperact Disord. 2011 Dec;3(4):319–326. PubMed PMID: 21833565.
   PubMedGoogle Scholar
• Wilens TE, Prince JB, Spencer T, et al. An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. Biol Psychiatry. 2003 Jul 1;54(1):9–16. PubMed PMID: 12842303.
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Pliszka S, Dulcan MK, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2 Suppl):26S–49S. PubMed PMID: 11833633.
   PubMed Web of Science ®Google Scholar
• Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry. 2010 Sep 3;10:67. PubMed PMID: 20815868; PubMed Central PMCID: PMCPMC2942810.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Morrison NR, Prince J. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother. 2011 Oct;11(10):1443–1465. PubMed PMID: 21955201; PubMed Central PMCID: PMCPMC3229037.
   PubMed Web of Science ®Google Scholar
• Weiss MD, Weiss JR. A guide to the treatment of adults with ADHD. J Clin Psychiatry. 2004;65 Suppl 3: 27–37. PubMed PMID: 15046533.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Swanson JM. Clinical practice: adult attention deficit-hyperactivity disorder. N Engl J Med. 2013 Nov 14;369(20):1935–1944. PubMed PMID: 24224626; PubMed Central PMCID: PMCPMC4827421.
   PubMed Web of Science ®Google Scholar
• Jensen PJ, Arnold LE, Richters JE, et al. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the multimodal treatment study of children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999 Dec ;56(12): 1088–1096. PubMed PMID: 10591284.
   PubMed Web of Science ®Google Scholar
• Group MTAC. National institute of mental health multimodal treatment study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics. 2004 Apr;113(4):762–769. PubMed PMID: 15060225.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Spencer T, Aleardi M, et al. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2004 Feb;24(1):24–29. PubMed PMID: 14709943.
   PubMed Web of Science ®Google Scholar
• Koesters M, Becker T, Kilian R, et al. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol. 2009 Sep;23(7):733–744. PubMed PMID: 18562416.
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001 Aug;58(8):775–782. PubMed PMID: 11483144.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Biederman J, Spencer TJ, et al. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006 Aug;11(8):625–639. PubMed PMID: 16871129.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Spencer TJ, Biederman J, et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry. 2001 Feb;158(2):282–288. PubMed PMID: 11156812.
   PubMed Web of Science ®Google Scholar
• Reimherr FW, Hedges DW, Strong RE, et al. Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial. Neuropsychiatr Dis Treat. 2005 Sep;1(3):245–251. PubMed PMID: 18568102; PubMed Central PMCID: PMCPMC2416755.
   PubMedGoogle Scholar
• Arnold VK, Feifel D, Earl CQ, et al. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. J Atten Disord. 2014 Feb;18(2):133–144. PubMed PMID: 22617860.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Prince J, et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996 Sep;153(9):1147–1153. PubMed PMID: 8780417.
   PubMed Web of Science ®Google Scholar
• Markowitz JS, Morrison SD, DeVane CL. Drug interactions with psychostimulants. Int Clin Psychopharmacol. 1999 Jan;14(1):1–18. PubMed PMID: 10221637.
   PubMed Web of Science ®Google Scholar
• Markowitz JS, Patrick KS. Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder. PubMed PMID: 11707061 Clin Pharmacokinet. 2001;4010:753–772.
   PubMed Web of Science ®Google Scholar
• Cohen LG, Biederman J, Wilens TE, et al. Desipramine clearance in children and adolescents: absence of effect of development and gender. J Am Acad Child Adolesc Psychiatry. 1999 Jan;38(1):79–85. PubMed PMID: 9893420.
   PubMed Web of Science ®Google Scholar
• Apostol G, Abi-Saab W, Kratochvil CJ, et al. Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology (Berl). 2012 Feb;219(3):715–725. PubMed PMID: 21748252.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Verlinden MH, Adler LA, et al. ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study. Biol Psychiatry. 2006 Jun 1;59(11):1065–1070. PubMed PMID: 16499880.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Gault LM, Childress A, et al. Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials. J Am Acad Child Adolesc Psychiatry. 2011 Jan;50(1):73–84 e1. PubMed PMID: 21156272; PubMed Central PMCID: PMCPMC3757954.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Waxmonsky J, Scott M, et al. An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005 Dec;15(6):947–955. PubMed PMID: 16379515.
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Faraone S, et al. A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol. 2006 Apr;26(2):163–166. PubMed PMID: 16633145.
   PubMed Web of Science ®Google Scholar
• Surman CB, Hammerness PG, Petty C, et al. A pilot open label prospective study of memantine monotherapy in adults with ADHD. World J Biol Psychiatry. 2013 May;14(4):291–298. PubMed PMID: 22436083.
   PubMed Web of Science ®Google Scholar
• Manor I, Ben-Hayun R, Aharon-Peretz J, et al. A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2012 Dec;73(12):1517–1523. PubMed PMID: 23290324.
   PubMed Web of Science ®Google Scholar
• Ernst M, Liebenauer LL, Jons PH, et al. Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety. Psychopharmacol Bull. 1996;32(3):327–334. PubMed PMID: 8961775.
   PubMedGoogle Scholar
• Schulz KP, Clerkin SM, Newcorn JH, et al. Guanfacine modulates the emotional biasing of amygdala-prefrontal connectivity for cognitive control. Eur Neuropsychopharmacol. 2014 Sep;24(9):1444–1453. PubMed PMID: 25059532; PubMed Central PMCID: PMCPMC4146697.
   PubMed Web of Science ®Google Scholar
• Connor DF, Findling RL, Kollins SH, et al. Effects of guanfacine extended release on oppositional symptoms in children aged 6–12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. CNS Drugs. 2010 Sep;24(9):755–768. PubMed PMID: 20806988.
   PubMed Web of Science ®Google Scholar
• Bloch Y, Aviram S, Segev A, et al. Methylphenidate reduces state anxiety during a continuous performance test that distinguishes adult ADHD patients from controls. J Atten Disord. 2017 Jan;21(1):46–51. PubMed PMID: 23413186.
   PubMed Web of Science ®Google Scholar
• Mattos P, Louza MR, Palmini AL, et al. A multicenter, open-label trial to evaluate the quality of life in adults with ADHD treated with long-acting methylphenidate (OROS MPH): concerta Quality of Life (CONQoL) study. J Atten Disord. 2013 Jul;17(5):444–448. PubMed PMID: 22334621.
   PubMed Web of Science ®Google Scholar
• Horrigan JP, Barnhill LJ. Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2000 Jun;61(6):414–417. PubMed PMID: 10901338.
   PubMed Web of Science ®Google Scholar
• Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the british association for psychopharmacology. J Psychopharmacol. 2005 Nov;19(6):567–596. PubMed PMID: 16272179.
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry. 1999 Nov 1;46(9):1234–1242. PubMed PMID: 10560028.
   PubMed Web of Science ®Google Scholar
• Adler L, Wilens T, Zhang S, et al. Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence. Am J Addict. 2009 Sep-Oct;18(5):393–401. PubMed PMID: 19874159 DOI: 10.3109/10550490903077663.
   PubMed Web of Science ®Google Scholar
• Heil SH, Holmes HW, Bickel WK, et al. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend. 2002 Jul 1;67(2):149–156. PubMed PMID: 12095664.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Adler LA, Weiss MD, et al. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008 Jul 1;96(1–2):145–154. PubMed PMID: 18403134.
   PubMed Web of Science ®Google Scholar
• Banaschewski T, Coghill D, Santosh P, et al. Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry. 2006 Dec;15(8):476–495. PubMed PMID: 16680409.
   PubMed Web of Science ®Google Scholar
• Efron D, Jarman F, Barker M. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: adouble-blind, crossover trial. Pediatrics. 1997 Dec;100(6):E6. PubMed PMID: 9382907.
   PubMed Web of Science ®Google Scholar
• Herlenius E, Lagercrantz H. Development of neurotransmitter systems during critical periods. Exp Neurol. 2004 Nov;190 Suppl 1:S8–21. PubMed PMID: 15498537.
   PubMed Web of Science ®Google Scholar
• Perugi G, Vannucchi G. The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder. Expert Opin Pharmacother. 2015;16(14):2193–2204. PubMed PMID: 26364896.
   PubMed Web of Science ®Google Scholar
• Asherson P, Young AH, Eich-Hochli D, et al. Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults. Curr Med Res Opin. 2014 Aug;30(8):1657–1672. PubMed PMID: 24804976.
   PubMed Web of Science ®Google Scholar
• Olfson M, Blanco C, Liu L, et al. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry. 2006 Jun;63(6):679–685. PubMed PMID: 16754841.
   PubMed Web of Science ®Google Scholar
• Pliszka SR, Crismon ML, Hughes CW, et al. The texas children’s medication algorithm project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):642–657. PubMed PMID: 16721314.
   PubMed Web of Science ®Google Scholar
• Cooper WO, Arbogast PG, Ding H, et al. Trends in prescribing of antipsychotic medications for US children. Ambul Pediatr. 2006 Mar-Apr;6(2):79–83. PubMed PMID: 16530143.
   PubMedGoogle Scholar
• Kutcher S, Aman M, Brooks SJ, et al. International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol. 2004 Jan;14(1):11–28. PubMed PMID: 14659983.
   PubMed Web of Science ®Google Scholar
• Yanofski J. The dopamine dilemma: using stimulants and antipsychotics concurrently. Psychiatry (Edgmont). 2010 Jun;7(6):18–23. PubMed PMID: 20622942; PubMed Central PMCID: PMCPMC2898838.
   PubMedGoogle Scholar
• Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2018 Nov 16;56:14–34. PubMed PMID: 30453134.
   PubMed Web of Science ®Google Scholar
• Dickstein DP, Towbin KE, Van Der Veen JW, et al. Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation. J Child Adolesc Psychopharmacol. 2009 Feb;19(1):61–73. PubMed PMID: 19232024; PubMed Central PMCID: PMCPMC2692186.
   PubMed Web of Science ®Google Scholar
• Ramtvedt BE, Roinas E, Aabech HS, et al. Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials. J Child Adolesc Psychopharmacol. 2013 Nov;23(9):597–604. PubMed PMID: 23659360; PubMed Central PMCID: PMCPMC3842881.
   PubMed Web of Science ®Google Scholar
• Skirrow C, Asherson P. Emotional lability, comorbidity and impairment in adults with attention-deficit hyperactivity disorder. J Affect Disord. 2013 May;147(1–3):80–86. PubMed PMID: 23218897.
   PubMed Web of Science ®Google Scholar
• Handen BL, McAuliffe S, Janosky J, et al. A playroom observation procedure to assess children with mental retardation and ADHD. J Abnorm Child Psychol. 1998 Aug;26(4):269–277. PubMed PMID: 9700519.
   PubMed Web of Science ®Google Scholar
• Pearson DA, Lachar D, Loveland KA, et al. Patterns of behavioral adjustment and maladjustment in mental retardation: comparison of children with and without ADHD. Am J Ment Retard. 2000 Jul;105(4):236–251. PubMed PMID: 10934566.
   PubMedGoogle Scholar
• Thapar A, Cooper M, Rutter M. Neurodevelopmental disorders. Lancet Psychiatry. 2017 Apr;4(4):339–346. PubMed PMID: 27979720.
   PubMed Web of Science ®Google Scholar
• Bloch MH, Panza KE, Landeros-Weisenberger A, et al. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):884–893. PubMed PMID: 19625978; PubMed Central PMCID: PMCPMC3943246.
   PubMed Web of Science ®Google Scholar
• Gilbert DL, Jankovic J. Pharmacological treatment of Tourette syndrome. J Obsessive Compuls Relat Disord. 2014;3(4):407–414.
   Web of Science ®Google Scholar
• Maia TV, Conceicao VA. The roles of phasic and tonic dopamine in tic learning and expression. Biol Psychiatry. 2017 Sep 15;82(6):401–412. PubMed PMID: 28734459.
   PubMed Web of Science ®Google Scholar
• Conceicao VA, Dias A, Farinha AC, et al. Premonitory urges and tics in Tourette syndrome: computational mechanisms and neural correlates. Curr Opin Neurobiol. 2017 Oct;46:187–199. PubMed PMID: 29017141.
   PubMed Web of Science ®Google Scholar
• Braun AR, Laruelle M, Mouradian MM. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications. PubMed PMID: 9295170 J Neural Transm (Vienna). 1997;1044–5:341–362.
   PubMed Web of Science ®Google Scholar
• Samaha AN, Seeman P, Stewart J, et al. “Breakthrough” dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time. J Neurosci. 2007 Mar 14;27(11):2979–2986. PubMed PMID: 17360921.
   PubMed Web of Science ®Google Scholar